Risk of recurrent ischemic stroke in young cryptogenic patients with embolic stroke of undetermined source

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00098892%3A_____%2F20%3AN0000115" target="_blank" >RIV/00098892:_____/20:N0000115 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/61989592:15110/20:73603729

Výsledek na webu

<a href="https://www.jns-journal.com/action/showPdf?pii=S0022-510X%2820%2930322-1" target="_blank" >https://www.jns-journal.com/action/showPdf?pii=S0022-510X%2820%2930322-1</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.jns.2020.116985" target="_blank" >10.1016/j.jns.2020.116985</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Risk of recurrent ischemic stroke in young cryptogenic patients with embolic stroke of undetermined source

Popis výsledku v původním jazyce

Introduction: Elderly cryptogenic ischemic stroke (IS) patients with embolic stroke of undetermined source (ESUS) have a high risk of recurrent IS (RIS) compared to other stroke subtypes. In young ESUS patients, different sources of embolism may be a cause and the risk of RIS remains not enough established. The aim was to assess and compare risk of RIS between ESUS and non ESUS patients <50 years. Methods: The study set consisted of young acute IS patients <50 years enrolled in the prospective HISTORY (Heart and Ischemic STrOke Relationship studY) study registered on ClinicalTrials.gov (NCT01541163). In all analyzed patients, the brain ischemia was confirmed on CT or MRI. All patients underwent identical diagnostic protocol including TEE and long-term ECG-Holter. Cause of IS was assessed according to the ASCOD classification. Results: Of 320 enrolled patients <50 years, 219 (68.4%) were identified as cryptogenic (119 males, mean age 41.4 ± 7.2 years) and 122 (38.1%) patients fulfilled the ESUS criteria. During the follow-up with a median of 34 months, three (2.5%) ESUS and 5 (5.2%) non-ESUS patients suffered from RIS (p = .471). One-year risk of RIS was 0.008 (95% CI: 0–0.025) for ESUS and 0.036 (95% CI: 0–0.076) for non-ESUS patients (p = .262). Conclusion: The risk of RIS was very low in ESUS patients and did not differ from those with non-ESUS. Our finding may indicate that antiplatelet therapy can be effective in the secondary prevention in young ESUS patients if high-risk sources of embolization are excluded extensively.

Název v anglickém jazyce

Risk of recurrent ischemic stroke in young cryptogenic patients with embolic stroke of undetermined source

Popis výsledku anglicky

Introduction: Elderly cryptogenic ischemic stroke (IS) patients with embolic stroke of undetermined source (ESUS) have a high risk of recurrent IS (RIS) compared to other stroke subtypes. In young ESUS patients, different sources of embolism may be a cause and the risk of RIS remains not enough established. The aim was to assess and compare risk of RIS between ESUS and non ESUS patients <50 years. Methods: The study set consisted of young acute IS patients <50 years enrolled in the prospective HISTORY (Heart and Ischemic STrOke Relationship studY) study registered on ClinicalTrials.gov (NCT01541163). In all analyzed patients, the brain ischemia was confirmed on CT or MRI. All patients underwent identical diagnostic protocol including TEE and long-term ECG-Holter. Cause of IS was assessed according to the ASCOD classification. Results: Of 320 enrolled patients <50 years, 219 (68.4%) were identified as cryptogenic (119 males, mean age 41.4 ± 7.2 years) and 122 (38.1%) patients fulfilled the ESUS criteria. During the follow-up with a median of 34 months, three (2.5%) ESUS and 5 (5.2%) non-ESUS patients suffered from RIS (p = .471). One-year risk of RIS was 0.008 (95% CI: 0–0.025) for ESUS and 0.036 (95% CI: 0–0.076) for non-ESUS patients (p = .262). Conclusion: The risk of RIS was very low in ESUS patients and did not differ from those with non-ESUS. Our finding may indicate that antiplatelet therapy can be effective in the secondary prevention in young ESUS patients if high-risk sources of embolization are excluded extensively.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30210 - Clinical neurology

Projekt

<a href="/cs/project/NV17-30101A" target="_blank" >NV17-30101A: Rizikové faktory ischemické cévní mozkové příhody u mladých pacientů: vztah k epidemiologickým, sociálním, ekonomickým parametrům a životnímu stylu</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2020

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of the Neurological Sciences

ISSN

0022-510X

e-ISSN

1878-5883

Svazek periodika

416

Číslo periodika v rámci svazku

September

Stát vydavatele periodika

NL - Nizozemsko

Počet stran výsledku

5

Strana od-do

116985

Kód UT WoS článku

000596476500049

EID výsledku v databázi Scopus

2-s2.0-85086523224